The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007–18)

(2021) George G Zhanel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative Genomic Analysis Provides Insights into the Evolution and Genetic Diversity of Community-Genotype Sequence Type 72 Staphylococcus aureus Isolates

(2021) Wangxiao Zhou et al.   mSystems

Emergence of Panton-Valentine leucocidin-positive ST8-methicillin-resistant Staphylococcus aureus (USA300 clone) in Korea causing healthcare-associated and hospital-acquired bacteraemia

(2016) J. Jung et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Increasing resistance to fusidic acid among clinical isolates of MRSA

(2016) Jann-Tay Wang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Usage of Topical Fusidic Acid and Rapid Clonal Expansion of Fusidic Acid–Resistant Staphylococcus aureus: A Cautionary Tale

(2014) Deborah A. Williamson et al.   CLINICAL INFECTIOUS DISEASES

Community-associated MRSA strain ST72-SCCmecIV causing bloodstream infections: clinical outcomes and bacterial virulence factors

(2014) K.-H. Park et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study

(2014) Ju Young Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Novel Staphylococcal Cassette Chromosomal Element, SCCfusC, CarryingfusCandspeGin Fusidic Acid-Resistant Methicillin-Resistant Staphylococcus aureus

(2013) Yu-Tzu Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of Global Patterns and the Genetics of Fusidic Acid Resistance

(2011) David J. Farrell et al.   CLINICAL INFECTIOUS DISEASES

Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008

(2010) M. Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical Isolates

(2010) H.-J. Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)

(2010) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Waves of resistance: Staphylococcus aureus in the antibiotic era

(2009) Henry F. Chambers et al.   NATURE REVIEWS MICROBIOLOGY